Cipralisant

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameCipralisant
Drug Alias NamePerceptin西拉利生西立桑特cipralisantumGT-2331
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H3 receptor antagonists
TargetsHistamine H3 receptor
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityCognition DisordersSleep Wake Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsAttention Deficit Disorder with HyperactivityCognition DisordersSleep Wake Disorders

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG